Skip to content

A retrospective study on pancreatic tumor diagnosis by multiparametric MRI

A retrospective study on pancreatic tumor diagnosis by multiparametric MRI - Multiparametric MRI in pancreatic tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051877
Enrollment
1000
Registered
2023-08-10
Start date
2023-08-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Sponsors

Shimane University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing pancreatic screening by intragastric, bulbous, and descending scans with ultrasound endoscopy between July 2017 and July 2023. 2) Patients who have taken MRI (including T1-weighted image, T2-weighted image, MRCP, diffusion-weighted image) within 3 months before and after endoscopic ultrasound.

Exclusion criteria

Exclusion criteria: Patients with suspected pancreatic tumor by endoscopic ultrasonography who have not undergone pathological evaluation such as fine-needle aspiration histology or pancreatic juice cytology under endoscopic ultrasonography, or whose results are unknown

Design outcomes

Primary

MeasureTime frame
Sensitivity, specificity, positive predictive value, negative predictive value

Countries

Japan

Contacts

Public ContactNOBUHIKO FUKUBA

Shimane University Internal medicine II

nfukuba@med.shimane-u.ac.jp0853-23-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026